Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52024-08-073OAAI
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settingsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-09-302OAAI
Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-05-1114PRE
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-02-1511OAAI
Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinationsCLINICAL MICROBIOLOGY AND INFECTIONIF8.52022-01-0111OAAI
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant BacteriaPEDIATRIC DRUGSIF3.32021-08-2628OAAI
Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-06-1719OA
The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studiesBMC INFECTIOUS DISEASESIF32021-06-0925OAAI
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunitiesCLINICAL MICROBIOLOGY AND INFECTIONIF8.52020-12-0118OAAI
Accelerating global innovation to address antibacterial resistance: introducing CARB-XNATURE REVIEWS DRUG DISCOVERYIF101.82016-07-2940PREAI
Rχ-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52008-10-0170OAAI
Crystal structure of the oxazolidinone antibiotic linezolid bound to the 50S ribosomal subunitJOURNAL OF MEDICINAL CHEMISTRYIF6.82008-05-22256PREAI
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogensANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52008-05-0166OAAI
Structural basis of the ribosomal machinery for peptide bond formation, translocation, and nascent chain progressionMOLECULAR CELLIF16.62003-01-01312OAAI
Ribosomal crystallography: From poorly, diffracting microcrystals to high-resolution structuresMETHODSIF4.32001-11-0125PREAI
Visualization of unwinding activity of duplex RNA by DbpA, a DEAD box helicase, at single-molecule resolution by atomic force microscopyPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12001-04-1060OAAI
The small ribosomal subunit from Thermus thermophilus at 4.5 Å resolution:: Pattern fittings and the identification of a functional sitePROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.11999-12-07119OAAI
Metal compounds as tools for the construction and the interpretation of medium-resolution maps of ribosomal particlesJOURNAL OF STRUCTURAL BIOLOGYIF5.11999-09-0128OA